Delivery Order SPE2DB22D2206-SPE2DB22FFA97
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $56,333.26 firm-fixed-price delivery order is for the supply of Sorafenib 200 mg tablets. The contract has an ultimate completion date of May 1, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range...
- This federal contract award, valued at $16,253.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4564742986 - Sorafenib 200 mg Tablets in 120-count bottles, with a completion date of May 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This federal contract award, SPE2DB20D3103|SPE2DB25FN1T9, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,603.82 firm fixed-price delivery order is for the supply of 4567678535 SORAFENIB 200 MG TABLET 120S. The contract has an ultimate completion date of March 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Sorafenib 200 mg tablets (120-count units) with a ceiling value of $14,770.22. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Sorafenib 200 mg tablets in quantities of 120 units, with a ceiling value of $28,126.60. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 8, 2025, with performance at the vendor's Conshohocken, Pennsylvania location. The contract carries no set-aside designation, reflecting AmerisourceBergen's capability to compete successfully...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The award, worth $10,685.92, is for the delivery of Inlyta 5 mg tablets. The contract has no set-aside designation, indicating full and open competition. As a major pharmaceutical distributor, Amerisourcebergen plays a critical role in supplying essential...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of pharmaceutical products and medical supplies. The $10,508.31 firm-fixed-price delivery order is for various medications, including Tagrisso 40 mg tablets, and has an ultimate completion date of May 31, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order worth $10,685.92 for the supply of 4560985523 INLYTA 5 MG TABLET 60S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense, and does not have a set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the...
- This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $11,721.43 for the supply of 4563606317 - Sunitinib Malate 50 MG Capsule. The award was made by the Defense Logistics Agency (DLA), a defense agency, with a period of performance through February 9, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $4,469.51, is for the delivery of 90 tablets of the medication Pirfenidone 801 mg. This is a Firm Fixed Price Delivery Order contract with a completion date of February 9, 2024. The contract was awarded on February 8, 2024 and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB22FFA97Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $84,773.77 firm fixed-price delivery order is for the supply of 4,558,627,779 units of Sorafenib 200 mg tablets. The contract has a completion date of September 29, 2022 and was awarded on September 28, 2022. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded several large Indefinite Delivery Contracts (IDCs) by the DLA Troop Support Medical, valued up to $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies in support of military and veteran healthcare programs globally. The company also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $84.8k | 9/28/22 |